glp-3rt vs retatrutide glp 3rt Retatrutide (GLP-3) New GLP-3 drug significantly slashes

Recently published efficacy and safety data are reviewed and the potential role of this novel GLP-1 receptor agonist in patient care is discussed

and speaking fees from Boehringer Ingelheim and Novo Nordisk Inc

A note on what this table is not telling you

How the Three Pathways Work Together What makes the design work is that the three receptor pathways complement each other: GLP-1 reduces energy intake (you eat less) GIP optimizes how that energy is used (better insulin sensitivity, favorable fat distribution) Glucagon increases energy expenditure (you burn more calories at rest and mobilize stored fat) The net effect: you eat less, your body uses energy more efficiently, and you burn more calories at rest

For these users, full adaptation can take up to six weeks

Ougaard, M